Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of the Safety and Effectiveness of the Oculeve Intranasal Lacrimal Neurostimulator in Patients With Dry Eye

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Bilateral dry eyes~* Capable of providing written informed consent~Exclusion Criteria:~* Chronic or recurring epistaxis (nosebleeds)~* Uncontrolled systemic disease~* Blood coagulation disorder~* Females who are pregnant, nursing or planning a pregnancy

- Gender: ALL
- Minimum Age: 22 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Intranasal Application (Type: EXPERIMENTAL): Intranasal Tear Neurostimulator device, intranasal application for approximately 3 minutes on Day 0 when the participant experienced an Ocular Discomfort Score (ODS) ≥3 at 2 or more consecutive time points in at least one eye during CAE exposure.
- Extranasal Application (Type: SHAM_COMPARATOR): Intranasal Tear Neurostimulator device, extranasal application for approximately 3 minutes on Day 0 when the participant experienced an ODS ≥3 at 2 or more consecutive time points in at least one eye during CAE exposure.

Based on this trial design, predict the completion outcome and termination type (if applicable).